Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
Authors:
Open Access
- 22 February 2022
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 24 (1) , 1-12
Abstract
Treatments used for rheumatoid arthritis (RA) are under investigation for their efficacy to prevent RA in at risk groups. It is therefore important to understand treatment preferences of those at risk. We systematically reviewed quantitative preference studies of drugs to treat, or prevent RA, to inform the design of further studies and trials of RA prevention. Stated preference studies for RA treatment or prevention were identified through a search of five databases. Study characteristics and results were extracted, and the relative importance of different types of treatment attributes was compared across populations. Twenty three studies were included 20 of RA treatments (18 of patients; 2 of the general public) and 3 prevention studies with first-degree relatives (FDRs). Benefits, risks, administration method and cost (when included) were important determinants of treatment choice. A benefit was more important than a risk attribute in half of the studies of RA treatment that included a benefit attribute and 2/3 studies of RA prevention. There was variability in the relative importance of attributes across the few prevention studies. In studies with non-patient participants, attributes describing confidence in treatment effectiveness/safety were more important determinants of choice than in studies with patients. Most preference studies relating to RA are of treatments for established RA. Few studies examine preferences for treatments to prevent RA. Given intense research focus on RA prevention, additional preference studies in this context are needed. Variation in treatment preferences across different populations is not well understood and direct comparisons are needed.Keywords
All Related Versions
This publication has 53 references indexed in Scilit:
- EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 2012
- Emerging Trends in Diagnosis and Treatment of Rheumatoid ArthritisPrimary Care: Clinics in Office Practice, 2010
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trialAnnals of the Rheumatic Diseases, 2010
- Understanding why rheumatoid arthritis patient treatment preferences differ by raceArthritis Care & Research, 2009
- Racial Disparities in Treatment Preferences for Rheumatoid ArthritisMedical Care, 2009
- Reliability of the Discrete Choice Experiment at the Input and Output Level in Patients with Rheumatoid ArthritisValue in Health, 2009
- Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitisJoint Bone Spine, 2008
- Patient preferences for treatment of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2004
- Empire Rheumatism CouncilAnnals of the Rheumatic Diseases, 1957